X0708 D LIVE 0001857044 Indaptus Therapeutics, Inc. 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 (646) 427-2727 DELAWARE INTEC PARENT, INC. Intec Parent Inc. Corporation true 2021 JEFFREY A. MECKLER 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director WALT A LINSCOTT 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer NIR SASSI 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer MICHAEL J. NEWMAN 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director ROGER WALTZMAN 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer HILA KARAH 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ANTHONY J. MADDALUNA 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director WILLIAM B. HAYES 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROGER J. POMERANTZ 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director MARK J GILBERT 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROBERT E. MARTELL 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-22 false true true false 0 Paulson Investment Company, LLC 5670 None None 10220 SW Greenburg Rd Suite 380 Portland OR OREGON 97223 All States false 227127 227127 0 Offering of unregistered warrants to purchase up to 1,817,017 shares of Common Stock. false 20 15527 0 The Issuer paid placement agent 7% of gross proceeds (excludes 42,553 warrants sold to Related Person) & issued placement agent warrants to purchase up to 124,212 shares (exercise price per share equal to $1.3125) & paid a non-accountable sum of $25,000. 0 Issuer expects to use proceeds from the offering to fund its research and development activities and for working capital and general corporate purposes. false Indaptus Therapeutics, Inc. /s/ Nir Sassi Nir Sassi Chief Financial Officer 2024-12-06